Recent News

By Region: North America

City’s Smallpox History Inspires New Exhibit

(NY1) Smallpox is the only disease that’s been completely wiped out across the globe but remains one of the most feared. Now, its unique connection to the city is on display at the New York Historical Society. NY1’s Kafi Drexel filed the following report. If there’s any doubt about what vaccination can do to protect Read More »

May 22, 2012
| Filed under North America, Agents & Toxins, and Public Health
Share

Clinic CBRN team conducts decontamination training

(Naval Health Clinic Public Affairs) Thirteen Sailors from Naval Health Clinic Patuxent River’s Chemical, Biological, Radiological and Nuclear Decontamination Team completed the “First Receiver Operations Training” exercise May 1-3. Led by the clinic’s emergency manager, Chief Hospital Corpsman Jeremy Raymond, the FROT exercise was conducted on clinic grounds, simulating the arrival of “contaminated” casualties seeking Read More »

May 21, 2012
| Filed under North America, Countermeasures, Policy & Initiatives, and Public Health
Share

Designer Flu: How scientists made a killer virus airborne — and who should know

(Science News) Last summer, scientists performed an experiment that could have been ripped from the script of a Hollywood thriller. Sealed off in high-tech laboratories in the Netherlands and Wisconsin, researchers transformed one of the world’s most deadly viruses, transmissible by direct contact, into versions capable of spreading through the air.

May 21, 2012
| Filed under Europe, North America, International, Policy & Initiatives, Public Health, and Research
Share

First-responders prepare for the worst

(Quad City Times) Hundreds of thousands of letters pass through the U.S. Postal Service’s processing facility in Milan each day. As part of the process, a biodetection system samples each piece of mail for anthrax. Should anthrax be detected, a plan is in place to handle the emergency and protect the lives of employees.

May 21, 2012
| Filed under North America, Biotechnology, Bioterrorism, Countermeasures, and Policy & Initiatives
Share

Emergent BioSolutions Receives FDA Approval for BioThrax Administered Intramuscularly in a Three-Dose Primary Series Followed by Booster Doses

(Press Release) Emergent BioSolutions Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved its supplemental Biologics License Application (sBLA) to change the administration schedule of BioThrax(R) (Anthrax Vaccine Adsorbed) to a three-dose primary series of intramuscular injections at 0, 1, and 6 months. The booster series consists of intramuscular injections at Read More »